Thursday, September 19, 2019

Boundless Bio Gets $46M For Treating Aggressive Cancers

San Diego-based Boundless Bio, a startup that is developing treatments for aggressive cancers, has raised $46.4M in a Series A funding round. The funding was co-led by ARCH Venture Partners and City Hill Ventures, and also included Vertex Ventures, GT Healthcare Capital Partners, Boxer Capital of the Tavistock Group, Alexandria Venture Investments,

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.

---